Merck Kgaa Adr Stock Today
| MKKGY Stock | USD 29.53 0.45 1.55% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Merck KGaA is trading at 29.53 as of the 25th of November 2024; that is 1.55% increase since the beginning of the trading day. The stock's open price was 29.08. Merck KGaA has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Merck KGaA ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of February 2024 and ending today, the 25th of November 2024. Click here to learn more.
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kgaa operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The company has 2.17 B outstanding shares. More on Merck KGaA ADR
Moving together with Merck Pink Sheet
| 0.97 | MKGAF | MERCK Kommanditgesells | PairCorr |
| 0.65 | HLN | Haleon plc | PairCorr |
| 0.9 | TAK | Takeda Pharmaceutical | PairCorr |
Moving against Merck Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Merck Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Merck KGaA ADR [MKKGY] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 88.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck KGaA's market, we take the total number of its shares issued and multiply it by Merck KGaA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Merck KGaA ADR classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 2.17 B outstanding shares.
Merck KGaA ADR has accumulated about 1.71 B in cash with 4.62 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.79.
Check Merck KGaA Probability Of Bankruptcy
Ownership AllocationMerck KGaA ADR maintains a total of 2.17 Billion outstanding shares. Roughly 99.97 % of Merck KGaA outstanding shares are held by general public with 0.03 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Merck Ownership Details
Merck KGaA ADR Risk Profiles
Merck Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Merck KGaA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Merck KGaA Corporate Management
| Matthias Heinzel | CEO Board | Profile | |
| Peter Guenter | CEO Board | Profile | |
| Barbara Weiland | Chief Officer | Profile | |
| Dirk Toepfer | Chief Officer | Profile | |
| Gerhard Schmitz | Head Accounting | Profile | |
| Belen MD | Chair CEO | Profile | |
| Kai Beckmann | Chief Administrative Officer, Member of the Executive Board | Profile |
Additional Tools for Merck Pink Sheet Analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.